August 26, 2020
Sanwa Kagaku Kenkyusho said on August 25 that it filed a new drug application (NDA) on the same day in Japan for SK-1403 (upacicalcet) for the treatment of secondary hyperparathyroidism (SHPT) in patients on dialysis. Upacicalcet, discovered by former Ajinomoto...read more